Fred R. Hirsch

1976–2025 年に発表

別表記
Fred R Hirsch
223
論文数
57,212
被引用数
115
h 指数
215
i10 指数

被引用数

Fred R. Hirsch の年別被引用数1963 年: 被引用 1 件1968 年: 被引用 1 件1971 年: 被引用 2 件1975 年: 被引用 1 件1976 年: 被引用 3 件1977 年: 被引用 1 件1978 年: 被引用 1 件1979 年: 被引用 2 件1980 年: 被引用 2 件1981 年: 被引用 4 件1982 年: 被引用 4 件1983 年: 被引用 8 件1984 年: 被引用 7 件1985 年: 被引用 6 件1986 年: 被引用 9 件1987 年: 被引用 9 件1988 年: 被引用 10 件1989 年: 被引用 11 件1990 年: 被引用 8 件1991 年: 被引用 6 件1992 年: 被引用 7 件1993 年: 被引用 9 件1994 年: 被引用 9 件1995 年: 被引用 10 件1996 年: 被引用 11 件1997 年: 被引用 5 件1998 年: 被引用 11 件1999 年: 被引用 10 件2000 年: 被引用 19 件2001 年: 被引用 14 件2002 年: 被引用 47 件2003 年: 被引用 92 件2004 年: 被引用 83 件2005 年: 被引用 133 件2006 年: 被引用 258 件2007 年: 被引用 291 件2008 年: 被引用 298 件2009 年: 被引用 322 件2010 年: 被引用 341 件2011 年: 被引用 292 件2012 年: 被引用 299 件2013 年: 被引用 375 件2014 年: 被引用 256 件2015 年: 被引用 288 件2016 年: 被引用 317 件2017 年: 被引用 433 件2018 年: 被引用 499 件2019 年: 被引用 2,062 件2020 年: 被引用 2,337 件2021 年: 被引用 2,321 件2022 年: 被引用 1,762 件2023 年: 被引用 1,297 件2024 年: 被引用 2,048 件2025 年: 被引用 986 件2026 年: 被引用 36 件1964〜1967 年は被引用が無いため表示していません1969〜1970 年は被引用が無いため表示していません1972〜1974 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 4,758 件、この内訳の 21.1%中国: 引用元論文 4,613 件、この内訳の 20.4%イタリア: 引用元論文 1,206 件、この内訳の 5.3%イギリス: 引用元論文 1,023 件、この内訳の 4.5%日本: 引用元論文 1,001 件、この内訳の 4.4%ドイツ: 引用元論文 890 件、この内訳の 4%フランス: 引用元論文 774 件、この内訳の 3.4%スペイン: 引用元論文 687 件、この内訳の 3.1%カナダ: 引用元論文 608 件、この内訳の 2.7%韓国: 引用元論文 606 件、この内訳の 2.7%オランダ: 引用元論文 512 件、この内訳の 2.3%オーストラリア: 引用元論文 482 件、この内訳の 2.1%
0%21.1%その他 24%

分野

  • Medicine67.6%
  • Biochemistry, Genetics and Molecular Biology22%
  • Immunology and Microbiology3.5%
  • Engineering1.7%
  • Computer Science1.3%
  • Social Sciences0.5%
  • その他3.4%

トピック

  • Lung Cancer Treatments and Mutations9.7%
  • Cancer Immunotherapy and Biomarkers8.6%
  • Lung Cancer Diagnosis and Treatment6.1%
  • Lung Cancer Research Studies5.4%
  • Cancer Genomics and Diagnostics3.6%
  • Radiomics and Machine Learning in Medical Imaging2.5%
  • その他64.1%

共著者

全論文

検索で開く
  1. PD-L1 as a biomarker of response to immune-checkpoint inhibitors

    著者: , , , , , , , , , - Nature Reviews Clinical Oncology 2021 被引用: 1,560

  2. Lung cancer: current therapies and new targeted treatments

    著者: , , , , , , - The Lancet 2016 被引用: 3,358

  3. The 2015 World Health Organization Classification of Lung Tumors

    著者: , , , , , , , , , , , , , , , , , , - Journal of Thoracic Oncology 2015 被引用: 4,546

  4. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Wilbur A. Franklin, Adi F. Gazdar, Michael K. Gould, P S Hasleton, Douglas W. Henderson, Bruce Johnson, David Johnson, Keith M. Kerr, Keiko Kuriyama, Jin Soo Lee, Vincent A. Miller, Iver Petersen, Victor L. Roggli, Rafael Rosell, Nagahiro Saijo, Erik Thunnissen, Ming‐Sound Tsao, David Yankelewitz - Journal of Thoracic Oncology 2011 被引用: 4,843

  5. Clinical insights into small cell lung cancer: Tumor heterogeneity, diagnosis, therapy, and future directions

    著者: , , , , , , , , , , , , , , , , - CA A Cancer Journal for Clinicians 2023 被引用: 343

  6. An IL-4 signalling axis in bone marrow drives pro-tumorigenic myelopoiesis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sacha Gnjatic, Emmanuelle Passegué, Seunghee Kim‐Schulze, Brian D. Brown, Fred R. Hirsch, Brian Kim, Thomas U. Marron, Miriam Mérad - Nature 2023 被引用: 184

  7. A Grading System for Invasive Pulmonary Adenocarcinoma: A Proposal From the International Association for the Study of Lung Cancer Pathology Committee

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Masayuki Noguchi, Claudia Poleri, Natasha Rekhtman, Ming‐Sound Tsao, Erik Thunnissen, William D. Travis, Yasushi Yatabe, Anja C. Roden, Jillian B. Daigneault, Ignacio I. Wistuba, Keith M. Kerr, Harvey I. Pass, Andrew G. Nicholson, Mari Mino–Kenudson - Journal of Thoracic Oncology 2020 被引用: 541

  8. Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non–Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michail Ignatiadis, Sunil Badve, Robert H. Pierce, Giuseppe Viale, Nicolas Sirtaine, Frédérique Penault‐Llorca, Tomohagu Sugie, Susan Fineberg, Soonmyung Paik, Ashok Srinivasan, Andrea L. Richardson, Yihong Wang, Ewa Chmielik, Jane Brock, Douglas B. Johnson, Justin M. Balko, Stephan Wienert, Veerle Bossuyt, Stefan Michiels, Nils Ternès, Nicole Burchardi, Stephen J. Luen, Peter Savas, Frederick Klauschen, Peter H. Watson, Brad H. Nelson, Carmen Criscitiello, Sandra A. O’Toole, Denis Larsimont, Roland de Wind, Giuseppe Curigliano, Fabrice André, Magali Lacroix‐Triki, Marc J. van de Vijver, Federico Rojo, Giuseppe Floris, Shahinaz Bedri, Joseph A. Sparano, David L. Rimm, Torsten O. Nielsen, Zuzana Kos, Stephen M. Hewitt, Baljit Singh, Gelareh Farshid, Sibylle Loibl, Kimberly H. Allison, Nadine Tung, Sylvia Adams, Karen Willard‐Gallo, Hugo M. Horlings, Leena Gandhi, André Moreira, Fred R. Hirsch, Maria Vittoria Dieci, María Urbanowicz, Iva Brčić, Konstanty Korski, Fabien Gaire, Hartmut Koeppen, Amy Lo, Jennifer M. Giltnane, Marlon C. Rebelatto, Keith E. Steele, Jiping Zha, Kenneth Emancipator, Jonathan Juco, Carsten Denkert, Jorge S. Reis‐Filho, Sherene Loi, Stephen B. Fox - Advances in Anatomic Pathology 2017 被引用: 799

  9. IASLC Multidisciplinary Recommendations for Pathologic Assessment of Lung Cancer Resection Specimens After Neoadjuvant Therapy

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ugo Pastorino, Luis Paz‐Ares, Giuseppe Pelosi, Claudia Poleri, Mariano Provencio, Anja C. Roden, Giorgio V. Scagliotti, Stephen G. Swisher, Erik Thunnissen, Ming‐Sound Tsao, Johan Vansteenkiste, Walter Weder, Yasushi Yatabe - Journal of Thoracic Oncology 2020 被引用: 450

  10. Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology

    著者: , , , , , , , , , , , , , , , , , , , , , - Archives of Pathology & Laboratory Medicine 2018 被引用: 931

  11. Tumor Mutational Burden and Efficacy of Nivolumab Monotherapy and in Combination with Ipilimumab in Small-Cell Lung Cancer

    著者: , , , , , , , , , , , , , , , - Cancer Cell 2018 被引用: 894

  12. PD-L1 Immunohistochemistry Comparability Study in Real-Life Clinical Samples: Results of Blueprint Phase 2 Project

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Thoracic Oncology 2018 被引用: 807

  13. PD-L1 Expression in Lung Cancer

    著者: , , , , - Journal of Thoracic Oncology 2016 被引用: 492

  14. Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma In Situ, Metastatic Tumor Deposits and Areas for Further Research

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michail Ignatiadis, Sunil Badve, Robert H. Pierce, Giuseppe Viale, Nicolas Sirtaine, Frédérique Penault‐Llorca, Tomohagu Sugie, Susan Fineberg, Soonmyung Paik, Ashok Srinivasan, Andrea L. Richardson, Yihong Wang, Ewa Chmielik, Jane B. Brock, Douglas B. Johnson, Justin M. Balko, Stephan Wienert, Veerle Bossuyt, Stefan Michiels, Nils Ternès, Nicole Burchardi, Stephen J. Luen, Peter Savas, Frederick Klauschen, Peter H. Watson, Brad H. Nelson, Carmen Criscitiello, Sandra A. O’Toole, Denis Larsimont, Roland de Wind, Giuseppe Curigliano, Fabrice André, Magali Lacroix‐Triki, Marc J. van de Vijver, Federico Rojo, Giuseppe Floris, Shahinaz Bedri, Joseph A. Sparano, David L. Rimm, Torsten O. Nielsen, Zuzana Kos, Stephen M. Hewitt, Baljit Singh, Gelareh Farshid, Sibylle Loibl, Kimberly H. Allison, Nadine Tung, Sylvia Adams, Karen Willard‐Gallo, Hugo M. Horlings, Leena Gandhi, André L. Moreira, Fred R. Hirsch, Maria Vittoria Dieci, María Urbanowicz, Iva Brčić, Konstanty Korski, Fabien Gaire, Hartmut Koeppen, Amy Lo, Jennifer M. Giltnane, Marlon C. Rebelatto, Keith E. Steele, Jiping Zha, Kenneth Emancipator, Jonathan Juco, Carsten Denkert, Jorge S. Reis‐Filho, Sherene Loi, Stephen B. Fox - Advances in Anatomic Pathology 2017 被引用: 720

  15. New promises and challenges in the treatment of advanced non-small-cell lung cancer

    著者: , , , , , , - The Lancet 2024 被引用: 367

  16. Predictive Biomarkers for Immunotherapy in Lung Cancer: Perspective From the International Association for the Study of Lung Cancer Pathology Committee

    著者: , , , , , , , , , , , , , , , , , - Journal of Thoracic Oncology 2022 被引用: 215

  17. PD-L1 Immunohistochemistry Assays for Lung Cancer: Results from Phase 1 of the Blueprint PD-L1 IHC Assay Comparison Project

    著者: , , , , , , , , , , , , , , , , , , , , , - Journal of Thoracic Oncology 2016 被引用: 1,254

  18. Low-Dose Apatinib Optimizes Tumor Microenvironment and Potentiates Antitumor Effect of PD-1/PD-L1 Blockade in Lung Cancer

    著者: , , , , , , , , , , , , , , , , , - Cancer Immunology Research 2019 被引用: 334

  19. Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC): A Statement Paper from the IASLC

    著者: , , , , , , , , , , , , , , , , , , , , , , - Journal of Thoracic Oncology 2018 被引用: 662

  20. The Promises and Challenges of Tumor Mutation Burden as an Immunotherapy Biomarker: A Perspective from the International Association for the Study of Lung Cancer Pathology Committee

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yasushi Yatabe, Akihiko Yoshida, Jillian B. Daigneault, Ahmet Zehir, Solange Peters, Ignacio I. Wistuba, Keith M. Kerr, John Longshore - Journal of Thoracic Oncology 2020 被引用: 292

  21. A Prospective, Multi-institutional, Pathologist-Based Assessment of 4 Immunohistochemistry Assays for PD-L1 Expression in Non–Small Cell Lung Cancer

    著者: , , , , , , , , , , , , , , , , , , , - JAMA Oncology 2017 被引用: 762

  22. IASLC Lung Cancer Staging Project: The New Database to Inform Revisions in the Ninth Edition of the TNM Classification of Lung Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Dean A. Fennell, Kwun M. Fong, Françoise Galateau-Sallé, Oliver Gautschi, Ritu R. Gill, Dorothy J. Giroux, Meredith Giuliani, Jin Mo Goo, Seiki Hasegawa, Fred R. Hirsch, Hans Hoffman, Wayne L. Hofstetter, James Huang, Philippe Joubert, Kemp H. Kernstine, Keith M. Kerr, Young Tae Kim, Dong Kwan Kim, Hedy L. Kindler, Yolande Lievens, Hui Liu, Donald E. Low, Gustavo Lyons, Heber MacMahon, Alyson Mahar, Mirella Marino, Edith M. Marom, José-María Matilla, Jan P. van Meerbeeck, Luis M. Montuenga, Andrew G. Nicholson, Katie Nishimura, Anna K. Nowak, Isabelle Opitz, Meinoshin Okumura, Raymond U. Osarogiagbon, Harvey I. Pass, Marc de Perrot, Helmut Prosch, David C. Rice, Andreas Rimner, Adam Rosenthal, Enrico Ruffini, Shuji Sakai, Paul Van Schil, Navneet Singh, Francisco Suárez, Ricardo Mingarini Terra, William D. Travis, Ming‐Sound Tsao, Paula A. Ugalde, Shun‐ichi Watanabe, Ignacio I. Wistuba, Murry W. Wynes, Yasushi Yatabe - Journal of Thoracic Oncology 2023 被引用: 131

  23. Extracellular vesicle PD-L1 dynamics predict durable response to immune-checkpoint inhibitors and survival in patients with non-small cell lung cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Experimental & Clinical Cancer Research 2022 被引用: 106

  24. TIM-3, a promising target for cancer immunotherapy

    著者: , , , , , - OncoTargets and Therapy 2018 被引用: 236